Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer

Clicks: 3
ID: 314122
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #325 of 341 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 341 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Breast cancer (bc) diagnosed during pregnancy or postpartum often presents with aggressive features, potentially influenced by hormonal, immunologic, and tissue remodeling changes. Studies have suggested that postpartum bc may be associated with worse outcomes, though most evidence is retrospective and constrained by methodological limitations. This study evaluated associations between pregnancy history, recency of childbirth, and long-term outcomes in a prospective cohort of young patients with early-stage bc. Patients and Methods Patients aged ≤40 years with stage I–III bc enrolled in the Young Women’s Breast Cancer Study were categorized at diagnosis as nulligravid, nulliparous, pregnant, or parous (≤5 vs 5 to 10 years postpartum). Analyses were stratified by bc subtype [estrogen receptor-positive [ER+]/HER2−, HER2+, and triple-negative (TNBC)], with distant recurrence-free survival (DRFS) as the primary endpoint. Results Among 859 patients, 257 (29.9%) were nulligravid, 50 (5.8%) nulliparous, 37 (4.3%) pregnant, and 515 (60.0%) parous. Pregnant patients had proportionally more TNBC, nodal involvement, T3/T4, and grade 3 tumors. After 11.1 years median follow-up, pregnancy or postpartum status was not independently associated with DRFS in multivariable models adjusted for age, tumor characteristics, and treatment, with consistent findings across ER+/HER2−, HER2+, and TNBC subtypes. Sensitivity analyses, including further categorization of postpartum diagnoses (<2 vs 2 to 5 years), yielded consistent results. Conclusions Pregnancy history and recency of childbirth were not independently associated with long-term DRFS. Despite more aggressive features at diagnosis, patients diagnosed during or after pregnancy had comparable outcomes after adjustment, suggesting no adverse prognostic impact. Clinical trial registration NCT01468246 (https://clinicaltrials.gov/study/NCT01468246?term=NCT01468246&rank=1)
Reference Key
openalex_W7161712734 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Guilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, Kate E. Dibble, Erica L. Mayer, Philip D. Poorvu, Kathryn J Ruddy, Yaileen D Guzman-Arocho, Laura C. Collins, Jeffrey Peppercorn, Lidia Schapira, Carmine Valenza, Virginia F. Borges, Nabihah Tayob, Steven E. Come, Ellen Warner, Kornelia Polyak, Eric P. Winer, Ann H Partridge
Journal JNCI Journal of the National Cancer Institute
Year 2026
DOI
10.1093/jnci/djag152
URL
https://doi.org/10.1093/jnci/djag152
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.